与多发性硬化症药物和处方相关的美国神经科医生的行业支付 (2015-2019):回顾性队列研究
Ahmed Sayed1,2,3, Ravi Gupta4, Reshma Ramachandran5,6
1Houston Methodist Debakey Heart & Vascular Center, Houston, Texas, USA.
BMJ open
|August 26, 2025
概括
几乎80%的神经病学家处方多发性硬化症 (MS) 药物, 这些支付与公司药物处方的可能性更高,
科学领域:
- 神经学
- 制药行业
- 医疗经济学
背景情况:
- 在多发性硬化症 (MS) 药物处方中, 制药公司向医生支付费用是常见的.
- 了解这些支付与处方模式之间的关联对于透明度和道德实践至关重要.
研究的目的:
- 量化行业向处方多发性硬化药物的神经科医生支付的普及率和财务规模.
- 调查接收行业支付与对多发性硬化药物处方行为的关系.
主要方法:
- 使用医疗保险D部分和开放支付数据库 (2015-2019) 的回顾性观察研究.
- 分析7401名神经病学家开处方的MS药物.
- 用于评估支付存在/规模与处方模式之间的关联的通用线性混合模型.
主要成果:
- 78.5%的神经科医生在2015-2019年期间获得了1.63亿美元的行业支付.
- 更高的处方量与收到支付的可能性和价值的增加有关.
- 收到付款的医生更有可能开处方给付款人的MS药物 (OR 1.13).
结论:
- 大多数处方MS药物的神经科医生都得到了行业的报酬.
- 有关公司的药物处方增加.
- 这种关联在较大,持续和较新的付款中更为强烈.
相关概念视频
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Prescription, Nonprescription and Orphan Drugs
1.5K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
691
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
691
Bioequivalence of Drugs: Drugs with Multiple Indications
230
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
230
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
527
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
527
Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20


